
|Articles|June 21, 2022
uMotif and ClinOne Announce Partnership
Single, integrated solution to provide eCOA and eConsent technology.
Advertisement
uMotif and ClinOne announced a partnership to provide the global life sciences industry with a single, integrated solution underpinned by a user experience that results in electronic clinical outcome assessments (eCOA) and electronic informed consent (eConsent) technology.
Read more about the partnership
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA and EMA Align on Ten Principles to Guide Artificial Intelligence Use in Drug Development
2
New Phase II Data Suggest Maternal Nipocalimab Does Not Disrupt Infant Immune Development in Severe HDFN
3
Global by Design: What 2026 Means for Sites, Sponsors, and Trial Operations
4
ACT Brief: FDA Capacity Strains Timelines, Sponsors Rethink Site Support, and Regulators Align on AI
5




